NewsMarketsSecond Cannabis Investment For UK Tobacco Firm

Second Cannabis Investment For UK Tobacco Firm

-

BRITISH tobacco giant Imperial has demonstrated its ambition in the legal cannabis industry with a second foray into the sector.

A recent £75m investment will provide Canadian firm Auxly Cannabis Group access to Imperial’s vaping technology.

This follows its initial investment into fellow UK firm Oxford Cannabis Technologies (OCT) in June, 2018.

Imperial, which makes the Lambert & Butler and Golden Virginia tobacco brands, say the Auxly move is part of an ongoing diversification strategy, which has seen it develop a growing presence in the heated tobacco and electronic vaping sectors.

Matthew Phillips, Imperial’s Chief Development Officer said: “Diversifying our Next Generation Product portfolio with this investment provides Imperial with further options for future growth and builds on last year’s investment in Oxford Cannabinoid Technologies.” 

Toronto-listed Auxly is strongly focused on developing the ‘Generation 2’ Canadian cannabis products, namely; edibles, vapes and lotions which were approved for sale last last year.

The deal gives Bristol-based Imperial a 19.9% stake in Auxly through a three-year convertible loan at a price of 81 cents per share.

OCT is a medical cannabis research company, Backed by Snoop Dogg’s venture firm and Star Wars actor Patrick Stewart, which says it aims to ‘unravel the secrets of a plant that has been stigmatised for decades’. 

Imperial is the latest consumer goods company to make a foray into cannabis. Last year Marlboro maker Altria Group announced a $2.4 billion investment in Cronos Group. 

Tilray has struck an agreement to collaborate on medical cannabis with Sandoz AG, part of the Novartis pharmaceutical Group and Canada’s Canopy Growth is receiving over $5 billion of investment from alcohol giant Constellation Brands.


Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Industry Concerns Surface Over No 10 Taskforce’s Hemp And Cannabis Proposals

THE initial warm welcome to proposals to make UK cannabinoid regulations a matter for the health authorities - not...

IM Cannabis Clinical Survey Confirms Effectiveness of Proprietary Strains in Alleviating Symptoms of Seven Key Health Conditions

IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC, CSE:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational...

Always Pure Organics Makes £3m Continental Swoop For Leading B2C Hemp And CBD Player

FAST-GROWING UK cannabis wholesaler Always Pure Organics has acquired two Belgian companies - Distribution Legal Hemp and NexGen -...

Little Green Pharma Picks Up Distressed Canadian LP’s Danish Cannabis Asset for £11.6m

AUSTRALIAN company Little Green Pharma has purchased the former Canopy Growth medicinal cannabis cultivation and manufacturing facility in Denmark...

New Era Beckons For Swiss Medical Cannabis Patients After Ten Years In Slow Lane

THE impending change to Switzerland’s medical cannabis laws could see the number of patients receiving treatment rise from 3,000...

How Britain’s Three Crown Dependencies Are Stealing A Cannabis March On the Mainland

FRUSTRATED by the UK Government’s stance the three UK Crown Dependencies of Jersey, Guernsey and the Isle of Man,...

Must read

Industry Concerns Surface Over No 10 Taskforce’s Hemp And Cannabis Proposals

THE initial warm welcome to proposals to make UK...

Little Green Pharma Picks Up Distressed Canadian LP’s Danish Cannabis Asset for £11.6m

AUSTRALIAN company Little Green Pharma has purchased the former...

You might also likeRELATED
Recommended to you